Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Medicare Final Rule for 2010
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Using Embryonic Stem Cells to Test Breast Cancer Genes
Sara Hartley, MDLinx Oncology
Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Pharmacology/Therapy



Latest (9) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma
Journal of Neuro-Oncology, 10/26/09
Sponsor
Predicting for activity of second-line trastuzumab-based therapy in Her2-positive advanced breast cancer
BMC Cancer, 10/23/09    Free full text
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09
The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer
European Journal of Cancer, 10/23/09
Phase I trial of vinflunine and pemetrexed in refractory solid tumors
Investigational New Drugs, 10/23/09
Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma
Investigational New Drugs, 10/23/09
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09
Favorable coagulation profile with fondaparinux after hip surgery in elderly patients
International Journal of Hematology, 10/23/09
Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Cancer Science, 10/23/09
Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma
Cancer Management and Research, 10/23/09
Romiplostim in chronic immune thrombocytopenic purpura
Clinical Therapeutics, 10/23/09    Revew Article
Update on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects
Hemoglobin, 10/23/09
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
Hemoglobin, 10/23/09
Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications
Hemoglobin, 10/23/09
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Investigational New Drugs, 10/23/09
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Oral Oncology, 10/23/09
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    9      10      11      12      13      14      15      16      17      18      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.